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Abstract
Purpose The aim of this multicentre study was to analyse the effects of patent sphincter lesions and previous sphincter repair on
the results of sacral neuromodulation (SNM) treatment on patients with faecal incontinence (FI).
Methods Patients examined by endoanal ultrasound (EAUS) with FI as the indication for SNM treatment were included in the
study. Data was collected from all the centres providing SNM treatment in Finland and analysed for differences in treatment
outcomes.
Results A total of 237 patients treated for incontinence with SNM had been examined by EAUS. Of these patients, 33 had a
history of previous delayed sphincter repair. A patent sphincter lesion was detected by EAUS in 128 patients. The EAUS finding
did not influence the SNM test phase outcome (p = 0.129) or the final treatment outcome (p = 0.233). Patient’s history of prior
sphincter repair did not have a significant effect on the SNM test (p = 0.425) or final treatment outcome (p = 0.442).
Conclusions Results of our study indicate that a sphincter lesion or previous sphincter repair has no significant effect on the
outcome of SNM treatment. Our data suggests that delayed sphincter repair prior to SNM treatment initiation for FI is not
necessary.
Keywords Faecal incontinence . Sacral neuromodulation . Endoanal ultrasound . Obstetric anal sphincter injury . Anal sphincter
repair
Introduction
Faecal incontinence (FI) has a serious negative effect on the
quality of life, and it is estimated that 4–12% of the general
population suffers from FI [1–3]. One of the main causes of
FI in women is obstetric trauma. Obstetric trauma occurs in
around 1–2% of all births and may present in the form of a
perineal tear or nerve damage [4]. As many as 51% of women
who have experienced an obstetric anal sphincter injury (OASI)
present with FI in the long term [5]. Over half (71%) of the
patients with a history of OASI have residual sphincter tears
detected on later imaging studies [6–8]. At the beginning of this
millennium, the gold standard for treatment of residual sphinc-
ter tears arising from OASI and other types of anal sphincter
injuries was the overlapping sphincteroplasty [9, 10].
The results of delayed sphincter repair, sometimes per-
formed years after initial trauma, have been disappointing,
with only a few patients having satisfactory continence at
long-term follow-up [11, 12]. This lack of positive effect is
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particularly evident in the elderly patient population [11].
Typically, physicians diagnosing patients with residual
sphincter lesions by endoanal ultrasound (EAUS) or magnetic
resonance tomography (MRT) have advocated a conservative
approach as the first line of treatment, except when such pa-
tients present with a perineal defect or rectovaginal fistula
[13]. Though most patients experience alleviation of symp-
toms with conservative treatment, there are patients who fail
to respond. Even if conservative treatment is effective at first,
symptoms of FI tend to re-emerge over time [10, 14, 15].
Symptoms of FI usually worsen after menopause due to weak-
ening of the pelvic floor musculature [16].
Since its introduction in the 1990s, sacral neuromodulation
(SNM) has established itself as the first line of treatment for FI
unresponsive to conservative methods [13, 17].
There is data indicating that intact sphincters are not nec-
essary to achieve successful SNM treatment results [18–20].
Studies on this matter have been conducted on small patient
populations (26–63 patients) with no long-term results
[20–22]. Contrary studies showing that intact sphincter mus-
culature has a positive effect on SNM treatment outcome have
also been published [23–25].
The aim of this study was to investigate the effect of dif-
ferent types of sphincter lesions detected on EAUS on SNM
treatment results in a national cohort. The secondary aim was
to compare the results of SNM treatment of patients with
previous sphincter repair to patients with sphincter lesions
and no previous sphincter repair prior to SNM treatment
initiation.
Methods
This is a national register-based retrospective study performed
in all centres providing SNM treatment in Finland. Clinical
data of patients selected for SNM testing was collected from
electronic patient register files from each of the participating
institutions for further analysis. Patients who had undergone
EAUS imaging, with FI as the primary or secondary indica-
tion for SNM treatment, were selected for further analysis.
Patients were divided into four groups according to the
EAUS finding: patients with normal sphincter musculature,
patients with an external anal sphincter (EAS) defect, patients
with an internal anal sphincter (IAS) defect and patients with a
combined IAS and EAS defect.
The groups were analysed for differences in age, sex,
aetiology of FI, Wexner scores, anomanometry test results,
number of attempted SNM tests, device settings during testing
and rates of complications during testing and after permanent
SNM implantation. Test phase and final treatment results were
also compared between the groups. Patients with previous
repair of the anal sphincter musculature were compared to
patients without a history of anal sphincter repair for the same
parameters mentioned above. Additionally, we compared the
test phase and final treatment success rates between patients
with a patent EAS defect and no previous sphincter repair to
patients with a history of previous sphincter repair.
As Finnish centres do not have a standardised method for
evaluating test phase or final treatment outcome, a universally
applicable definition of treatment success was chosen. Test
phase success was defined by patients advancing to permanent
SNM implantation. Overall treatment success was defined by
patients having a working permanent SNM device with sub-
jective positive effects on the symptoms on FI at the time data
collection ended on April 1, 2017.
The SNM implantation was performed as a two-stage pro-
cedure. Patients were first implanted with a test lead. This
procedure was conducted under local anaesthesia, unless
patient-dependent factors required otherwise. From 2002, all
patients were implanted with a tined lead (see Appendix 2).
All centres used a two-week evaluation period; the success of
the test period was evaluated by either a drop in FI episodes
according to a bowel diary or a drop in Wexner scores. All
centres used subjective patient feedback as the main indication
for permanent SNM implantation. All patients were evaluated
1, 6, and 12 months after the permanent modulator implanta-
tion. After one year of follow-up, patients were instructed to
contact the incontinence nurse if any problems arouse with the
SNM device. Subjective loss of effect in the presence of a
working SNM was an indication for explantation of the
SNM device.
Imaging data was collected from written imaging reports.
The EAUS imaging devices were all supplied by BK
Medical®. The models used varied over the period of 1999–
2017 (for further information, see Appendix 1). All of the
EAUS imaging studies were conducted by colorectal sur-
geons. All of the implanted devices were supplied by
Medtronic® Inc. (Minneapolis, Minnesota, USA; see
Appendix 2).
Microsoft® Excel® for MAC version 15.13.1 was used
for data collection. IBM® SPSS® software Version 25 was
used for statistical analysis. The Shapiro-Wilk test was per-
formed to check for normality, where p > 0.05 indicated a
normal distribution. None of the values expressed a normal
distribution, so nonparametric tests were used. For contin-
uous values, the Kruskal-Wallis independent samples test
was used, where a p value of < 0.05 indicated a significant
difference in means. When a significant difference was not-
ed, the groups were further analysed with the Mann-
Whitney U test to determine the differences between
groups. The p values were corrected using Bonferroni’s
method. Either Pearson’s chi-square test or the Fisher’s ex-
act test was used to compare nominal values. The overall
change in pre- and post-testing Wexner scores was tested
using the single sample t test. A p value of <0.05 was set
as statistically significant.
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This study was conducted in accordance with Finnish
Medical Research Act 488/199, 295/2004 and approved by
the Ethics Committee of the Hospital District of Southwest
Finland (ETMK: 163/1801/2015).
Results
There were 237 patients examined by EAUS. One patient was
excluded from further analysis because the indication for ini-
tiating SNM treatment was constipation (Fig. 1). Of the re-
maining 236 patients, 33 had a history of delayed sphincter
repair. Of these, 31 patients had undergone an overlapping
sphincteroplasty and two patients a graciloplasty procedure.
Over half of the patients (n = 17; 51.5%) who had undergone
delayed sphincter repair had a patent EAS defect detected on
EAUS. In total, there were 128 patients with sphincter defects
detected by EAUS. The majority of the patients were female
(n = 215; 91.1%), and the median age of patients was
64.5 years. The most common indication for initiating SNM
treatment was OASI (n = 93; 39.4%). Almost all of the pa-
tients who had undergone delayed sphincter repair had either
a history of OASI (n = 29; 87.9%) or iatrogenic injury (n = 3;
9.1%) (p < 0.001). Only 18 (7.6%) of the test procedures were
conducted under general anaesthesia. Of the 236 patients in-
cluded in the study, 171 (73.1%) had a successful test phase
and advanced to permanent SNM implantation; of these, 160
(60.6%) had a successful final treatment outcome. Themedian
follow-up time from permanent SNM implantation was
1.3 years (range 14 days–13.6 years).
Effects of different types of sphincter lesions
on the SNM treatment outcome
As patients were divided into four subgroups according to the
EAUS finding, there was no significant difference in the age
of patients between the groups (p = 0.558). Significantly more
women had an EAS or a combined EAS and IAS defect com-
pared to male patients (p = 0.008).
No significant differences between the groups in the
squeeze (p = 0.182) or resting pressures (p = 0.254) were
shown in the anomanometric study (Table 1). All of the pa-
tients’ pre-testing and during-testing Wexner scores changed
significantly, with scores dropping from a mean of 15.7 to
8.81 (p < 0.001), with only 28 (11.8%) patients having filled
out the Wexner questionnaire after test initiation. There was
no difference between the groups in the mean Wexner scores
prior to testing (p = 0.439) or in the values obtained during
testing (p = 0.279; see Table 2). An average of 1.13 (SD) tests
were performed per patient, with 26 patients undergoing test-
ing more than once, with no differences between groups (p =
0.409).
The test phase and permanent SNM settings are presented
in Table 3. There was no difference in complication frequen-
cies between patients in different groups (p = 0.194). Infection
(n = 15) and postoperative pain (n = 11) were the most com-
mon complications arising during SNM testing.
Patients with a combined EAS and IAS defect had most
successful test phases, with 84.0% of these patients advancing
from the test phase to permanent SNM implantation. Patients
with an EAS defect had the least successful test phases, with
64.0% of the patients advancing to permanent SNM
Fig. 1 Flowchart showing the
selection of patients
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implantation. Of the patients with normal sphincter muscula-
ture, 73.8% had a successful test phase outcome. These dif-
ferences were not significant (p = 0.129). Neither was there a
significant difference between the groups in the final treatment
outcome (p = 0.233).
Effect of delayed sphincter repair on SNM treatment
outcomes
Altogether, 33 (14.9%) of the patients included in the study
had a history of previous delayed sphincter repair. Two pa-
tients had undergone a graciloplasty procedure, whereas the
rest of the patients had undergone an overlapping
sphincteroplasty. Only one male patient had undergone
sphincter repair, which was due to iatrogenic sphincter injury.
There was no difference between patients with previous
delayed sphincter repair and patients with no history of repair
in the anomanometry study results (Table 1).
There were proportionally more patients with a history of
delayed sphincter repair (n = 9, 28.1%) who had been tested
for SNM implantation more than once compared to patients
with no history of sphincter reconstructive surgery (n = 17,
8.5%) (p = 0.005). Patients with previous sphincter recon-
structive surgery had longer signal length settings during test-
ing compared to patients with no history of surgical sphincter
reconstructive surgery (p = 0.016). Otherwise, no differences
in the test phase signal settings were detected.
A history of prior sphincter reconstructive surgery did not
have a significant effect on the test results, as 26 (78.8%) of
the patients with prior sphincter reconstructive surgery and
145 (72.1%) of the patients with no sphincter reconstructive
surgery advanced to permanent SNM implantation (p =
0.425). Neither did prior sphincter reconstructive surgery af-
fect the final treatment outcome, with 22 (66.7%) of the pa-
tients with a history of sphincter reconstructive surgery and
118 (59.6%) without previous sphincter repair having a suc-
cessful final treatment outcome (p = 0.442). A total of 58 pa-
tients had a patent EAS defect and no history of sphincter
repair prior to SNM test initiation. When these patients were
compared to patients with a history of prior sphincter repair,
there was no difference in the test phase (p = 0.618) or final
treatment outcomes (p = 0.738).
Discussion
This is the largest study in a national multicentre setting of the
effects of anal sphincter lesions on SNM treatment outcomes
published to date. Our study features a relatively large hetero-
geneous cohort of patients who had undergone EAUS imag-
ing prior to SNM testing.
There were differences in SNM test settings among patients
with different types of sphincter lesions. It would appear that a
patent IAS defect had an effect on the signal length setting
during the test phase. An IAS defect did not have an impact on
the permanent SNM settings. Patients with a history of de-
layed sphincter repair had had more test attempts per patient
compared to patients with no history of sphincter repair. The
clinical relevance of these findings is unclear.
A patent sphincter defect or a history of previous sphincter
reconstructive surgery had no effect on the SNM test or final
treatment outcome. This finding supports results from earlier
studies that an intact sphincter is not a prerequisite for suc-
cessful SNM treatment [26, 27]. Results of this study indicate
that EAUS findings do not influence the outcome of SNM
treatment. Though EAUS is a safe and fast diagnostic tool,
the imaging process could cause patients discomfort.
Furthermore, the hardware for EAUS imaging is not widely
available in Finland. Imaging of the sphincters by EAUS
seems to lack diagnostic value when considering SNM treat-
ment outcomes.
Table 1 Anomanometry results of patients (n = 90; 38.1%) with





Normal sphincters 72 37.35
Pathologic EAS 44.15 31
Pathologic IAS 83 38.4
Pathologic EAS and IAS 46.5 23
p value1 0.360 0.607
Sphincter repair 48 30
No sphincter repair 65.3 36
p value2 0.933 0.859
1Kruskal-Wallis test, 2Mann-Whitney U test
EAS external anal sphincter, IAS internal anal sphincter





Normal sphincters 15 7
Pathologic EAS 15.5 10
Pathologic IAS 17 14
Pathologic EAS and IAS 16 6
p value 0.439 0.163
Number of patients analysed 192 73
Sphincter repair 16 15
No sphincter repair 16 6.5
p value 0.696 0.789
Number of patients analysed 190 72
p values obtained using the single sample t test
EAS external anal sphincter, IAS internal anal sphincter
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Our results indicate no difference in treatment success rates
between patients with a patent EAS defect who have been
implanted before any attempts at sphincter repair compared to
patients with previous sphincter reconstructive surgery. This
raises the question of the necessity of sphincter reconstructive
surgery prior to SNM treatment. Earlier studies have shown that
a sphincter lesion of up to 180 degrees does not have an effect
on SNM treatment outcome [28, 29]. A small study has even
shown SNM to be superior to sphincteroplasty when compar-
ing postoperative Wexner scores [20]. It can also be argued that
the delayed surgical sphincter reconstructive surgery is unnec-
essary and patients with persistent obstetric sphincter or iatro-
genic injury should be considered primarily for SNM treatment.
There is evidence for refraining from delayed sphincter recon-
structive surgery after obstetric sphincter injury in the elderly
population, due to disappointing results [12]. However, it must
be emphasised that a successful primary sphincter repair after
OASI has the best medium- and long-term results [30]. The
success of delayed sphincter reconstructive surgery may de-
pend on the time from the initial injury (i.e. weeks, months or
years). Sincewe had not included the delay from initial injury to
sphincter reconstructive surgery in our data collection protocol,
further research is needed to answer this question.
This was a retrospective registry study with all the limitations
of such studies. Themain limitation of this studywas the absence
of a uniform treatment success evaluation method. This high-
lights the need for a centralised national database of SNM pa-
tients. Further limitations arise from the fact that data on EAUS
findings was collected from written imaging reports saved in the
patients’ files in the digital databases of each hospital.
Conclusion
In this Finnish national cohort of patients, the presence of a
patent sphincter defect or a history of delayed sphincter recon-
structive surgery did not have any significant effect on the
outcome of SNM treatment for FI. The results of this study
support the argument of advocating SNM treatment in place of
delayed sphincter reconstructive surgery for patients with ob-
stetric or iatrogenic sphincter injuries, regardless of the EAUS
findings.
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Appendix 1
The EAUS imaging devices were all supplied by BKMedical.
The models varied over the period of 1999–2017, withmodels
Cheetah and Leopard being in use from 1999 to 2002, Falcon
from 1999 to 2009, Hawk from 2000 to 2009, Pro Focus
Yellow and Green from 2005 to 2010, Pro Focus Blue from
2005 to 2012, Pro Focus Ultraview and Flex Focus 400 from
2009 to 2017, Flex Focus 500 from 2011 to 2017, Flex Focus
800 from 2012 to 2017 and bk3000 and bk5000 from 2014 to
2017. Transducers used with these scanners have varied over
the period from 1999 to 2017, with model 1850 being in use
from 1999 to 2012, model 2050 from 1999 to 2012, model
2052 from 2005 to 2017 and model 20R3 from 2015 to 2017
Appendix 2
All of the implanted devices were supplied by Medtronic®
Inc. (Minneapolis, Minnesota, USA). Until 2002, a non-tined
lead was used. Model 3057 PNE (Medtronic® Inc.
Minneapolis, USA) was used for temporary evaluation of
therapeutic success. A Quadripolar leadmodel 3093 tined lead
was used from 2003 and changed to model 3889 in 2014
Table 3 Sacral neuromodulator settings in each group during the test phase






Stimulation amplitude (V) 1.16 1.21 1.03 0.99 112 0.630
Stimulation frequency (Hz) 18.27 17.31 15.32 19.40 103 0.148
Stimulation signal length (ms) 207.31 207.0 223.79 203.68 97 0.002
Permanent modulator settings
Stimulation amplitude (V) 1.19 1.22 1.25 1.27 114 0.793
Stimulation frequency (Hz) 16.46 14.88 15.55 15.7 109 0.673
Stimulation signal length (ms) 207.17 230.0 221.0 204.44 108 0.099
1Kruskal-Wallis test
EAS external anal sphincter, IAS internal anal sphincter
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